25 results
8-K
EX-10.4
SPRY
ARS Pharmaceuticals Inc
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
-bribery or corruption violations;
it will comply with all Applicable Laws and the terms of this Agreement in its performance of its obligations hereunder
8-K
EX-10.3
029fh8
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-10.2
506rhh81qriw6
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
8-K
EX-2.1
43k6iutpiijw2p3yn3
8 Nov 22
ARS Pharmaceuticals Closes Merger with Silverback Therapeutics
4:51pm
DEFM14A
d4hjg8xb0oi3zp
6 Oct 22
Proxy related to merger
4:16pm
PRER14A
ajh0adr 6h8
16 Sep 22
Preliminary revised proxy
4:56pm
PREM14A
076ekqxphc5md20o276q
11 Aug 22
Preliminary proxy related to merger
5:22pm
DEFA14A
6b8nc6
21 Jul 22
Additional proxy soliciting materials
5:05pm
8-K
EX-2.1
ya59xb enys
21 Jul 22
Silverback Therapeutics and ARS Pharmaceuticals Announce Merger
5:01pm
10-K
t330gxzm
29 Mar 21
Annual report
4:13pm
424B4
3mpgfph
4 Dec 20
Prospectus supplement with pricing info
4:04pm
S-1/A
EX-1.1
gs4c0
30 Nov 20
IPO registration (amended)
6:06am
S-1/A
r5cgi uw0xakjfgc
30 Nov 20
IPO registration (amended)
6:06am
S-1
47swuy131 81ls
10 Nov 20
IPO registration
4:46pm